Bishak Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 0.81 Cr
as on 17-07-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.14 Cr
as on 17-07-2024
- Satisfied Charges ₹ 5.00 Cr
as on 17-07-2024
- Revenue 23.66%
(FY 2023)
- Profit 80.62%
(FY 2023)
- Ebitda 62.05%
(FY 2023)
- Net Worth 25.23%
(FY 2023)
- Total Assets 21.95%
(FY 2023)
About Bishak Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.81 Cr.
The company currently has active open charges totaling ₹3.14 Cr. The company has closed loans amounting to ₹5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vasundhara Kamineni and Gayatri Kamineni serve as directors at the Company.
- CIN/LLPIN
U51909TG2010PTC067898
- Company No.
067898
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bishak Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vasundhara Kamineni  | Director | 09-Apr-2010 | Current |
| Gayatri Kamineni | Director | 09-Apr-2010 | Current |
Financial Performance and Corporate Structure Insights of Bishak Pharma.
Bishak Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.66% increase. The company also saw a substantial improvement in profitability, with a 80.62% increase in profit. The company's net worth Soared by an impressive increase of 25.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bishak Pharma?
In 2023, Bishak Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kamineni Life Sciences Private Limited
Active 18 years 12 daysVasundhara Kamineni is a mutual person
Kamineni Fertility Center Private Limited
Active 14 years 3 monthsVasundhara Kamineni and Gayatri Kamineni are mutual person
Kamineni Health Care Private Limited
Active 16 years 10 monthsVasundhara Kamineni is a mutual person
Kamineni Hospitals Private Ltd.
Active 35 years 7 monthsVasundhara Kamineni and Gayatri Kamineni are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Dec 2023 | ₹1.00 Cr | Open |
Others Creation Date: 10 Oct 2022 | ₹3.00 M | Open |
Others Creation Date: 10 Oct 2022 | ₹3.00 M | Open |
How Many Employees Work at Bishak Pharma?
Bishak Pharma has a workforce of 27 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bishak Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bishak Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
